SEC Form 4 · accession 0001209191-17-065201
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Hirsch
Director · 10% Owner
Period of report
Dec 8, 2017
Accepted (ET)
Dec 12, 2017 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 8, 2017 | S | 980,350 | $17.34 | D | 2,276,222 | I | By LVP |
| Common StockF1,F2 | Dec 8, 2017 | S | 19,650 | $17.34 | D | 45,620 | I | By LCA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Following the transactions reported herein, the reporting person has ceased to be the direct or indirect beneficial owner of more than 10% of any class of the Issuer's equity securities.
- F2Reflects securities held by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA"). Longitude Capital Partners, LLC ("LCP") is the general partner of LVP and LCA. The reporting person is a member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. The reporting person disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of his pecuniary interest therein.